VSNL1 and amyloidosis: Several studies have shown that in patients with early symptomatic AD, the level of VILIP-1 in cerebrospinal fluid is closely related to whole and regional brain atrophy and is associated with amyloid load in normal individuals in cognition (Tarawneh et al., 2012).